David M. Knott’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-16,820
| Closed | -$177K | – | 124 |
|
|
2019
Q3 | $177K | Sell |
16,820
-8,750
| -34% | -$92.1K | 0.07% | 80 |
|
|
2019
Q2 | $435K | Buy |
25,570
+12,957
| +103% | +$220K | 0.18% | 60 |
|
|
2019
Q1 | $425K | Buy |
12,613
+1,470
| +13% | +$49.5K | 0.17% | 63 |
|
|
2018
Q4 | $325K | Buy |
11,143
+2,110
| +23% | +$61.5K | 0.15% | 63 |
|
|
2018
Q3 | $556K | Buy |
9,033
+1,368
| +18% | +$84.2K | 0.18% | 60 |
|
|
2018
Q2 | $566K | Buy |
7,665
+900
| +13% | +$66.5K | 0.21% | 60 |
|
|
2018
Q1 | $444K | Buy |
6,765
+767
| +13% | +$50.3K | 0.18% | 64 |
|
|
2017
Q4 | $504K | Buy |
5,998
+300
| +5% | +$25.2K | 0.2% | 59 |
|
|
2017
Q3 | $658K | Buy |
5,698
+3,700
| +185% | +$427K | 0.28% | 47 |
|
|
2017
Q2 | $233K | Buy |
1,998
+940
| +89% | +$110K | 0.1% | 68 |
|
|
2017
Q1 | $131K | Buy |
+1,058
| New | +$131K | 0.06% | 53 |
|